ID   GNAO_HUMAN              Reviewed;         354 AA.
AC   P09471; P29777; Q8TD72; Q9UMV4;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   05-OCT-2016, entry version 175.
DE   RecName: Full=Guanine nucleotide-binding protein G(o) subunit alpha;
GN   Name=GNAO1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND ALTERNATIVE SPLICING.
RX   PubMed=1901650; DOI=10.1073/pnas.88.8.2974;
RA   Tsukamoto T., Toyama R., Itoh H., Kozasa T., Matsuoka M., Kaziro Y.;
RT   "Structure of the human gene and two rat cDNAs encoding the alpha
RT   chain of GTP-binding regulatory protein Go: two different mRNAs are
RT   generated by alternative splicing.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:2974-2978(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RX   PubMed=3124840; DOI=10.1016/0006-291X(88)90463-9;
RA   Lavu S., Clark J., Swarup R., Matshushima K., Paturu K., Moss J.,
RA   Kung H.-F.;
RT   "Molecular cloning and DNA sequence analysis of the human guanine
RT   nucleotide-binding protein Go alpha.";
RL   Biochem. Biophys. Res. Commun. 150:811-815(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS ALPHA-1 AND ALPHA-2).
RC   TISSUE=Brain;
RA   Puhl H.L. III, Ikeda S.R., Aronstam R.S.;
RT   "cDNA clones of human proteins involved in signal transduction
RT   sequenced by the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (MAR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 246-354 (ISOFORM ALPHA-2).
RC   TISSUE=Myometrium;
RX   PubMed=10330115; DOI=10.1095/biolreprod60.6.1528;
RA   Duc-Goiran P., Bourgeois C., Mignot T.M., Robert B., Tanguy G.,
RA   Ferre F.;
RT   "Identification and expression of GO1 and 2 alpha-subunit transcripts
RT   in human myometrium in relation to pregnancy.";
RL   Biol. Reprod. 60:1528-1535(1999).
RN   [5]
RP   MYRISTOYLATION AT GLY-2, CLEAVAGE OF INITIATOR METHIONINE, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=25255805; DOI=10.1038/ncomms5919;
RA   Thinon E., Serwa R.A., Broncel M., Brannigan J.A., Brassat U.,
RA   Wright M.H., Heal W.P., Wilkinson A.J., Mann D.J., Tate E.W.;
RT   "Global profiling of co- and post-translationally N-myristoylated
RT   proteomes in human cells.";
RL   Nat. Commun. 5:4919-4919(2014).
RN   [6]
RP   VARIANTS EIEE17 GLY-174; 191-THR--PHE-197 DEL; ARG-203 AND ASN-279,
RP   AND CHARACTERIZATION OF VARIANTS EIEE17 GLY-174; 191-THR--PHE-197 DEL;
RP   ARG-203 AND ASN-279.
RX   PubMed=23993195; DOI=10.1016/j.ajhg.2013.07.014;
RA   Nakamura K., Kodera H., Akita T., Shiina M., Kato M., Hoshino H.,
RA   Terashima H., Osaka H., Nakamura S., Tohyama J., Kumada T.,
RA   Furukawa T., Iwata S., Shiihara T., Kubota M., Miyatake S.,
RA   Koshimizu E., Nishiyama K., Nakashima M., Tsurusaki Y., Miyake N.,
RA   Hayasaka K., Ogata K., Fukuda A., Matsumoto N., Saitsu H.;
RT   "De Novo mutations in GNAO1, encoding a Galphao subunit of
RT   heterotrimeric G proteins, cause epileptic encephalopathy.";
RL   Am. J. Hum. Genet. 93:496-505(2013).
RN   [7]
RP   VARIANT EIEE17 ARG-40.
RX   PubMed=26485252; DOI=10.1016/j.cca.2015.10.011;
RA   Law C.Y., Chang S.T., Cho S.Y., Yau E.K., Ng G.S., Fong N.C.,
RA   Lam C.W.;
RT   "Clinical whole-exome sequencing reveals a novel missense pathogenic
RT   variant of GNAO1 in a patient with infantile-onset epilepsy.";
RL   Clin. Chim. Acta 451:292-296(2015).
CC   -!- FUNCTION: Guanine nucleotide-binding proteins (G proteins) are
CC       involved as modulators or transducers in various transmembrane
CC       signaling systems. The G(o) protein function is not clear.
CC       Stimulated by RGS14.
CC   -!- SUBUNIT: Interacts with RGS14 (By similarity). G proteins are
CC       composed of 3 units; alpha, beta and gamma. The alpha chain
CC       contains the guanine nucleotide binding site. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000250|UniProtKB:P18872}. Membrane {ECO:0000305}; Lipid-
CC       anchor {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Alpha-1;
CC         IsoId=P09471-1; Sequence=Displayed;
CC       Name=Alpha-2;
CC         IsoId=P09471-2, P29777-1;
CC         Sequence=VSP_031250;
CC   -!- DISEASE: Epileptic encephalopathy, early infantile, 17 (EIEE17)
CC       [MIM:615473]: A severe neurologic disorder characterized by onset
CC       of intractable seizures in the first weeks or months of life and
CC       usually associated with EEG abnormalities. Affected infants have
CC       very poor psychomotor development and may have brain
CC       abnormalities, such as cerebral atrophy or thin corpus callosum.
CC       Some patients may show involuntary movements.
CC       {ECO:0000269|PubMed:23993195, ECO:0000269|PubMed:26485252}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M60164; AAA52585.1; -; Genomic_DNA.
DR   EMBL; M60156; AAA52585.1; JOINED; Genomic_DNA.
DR   EMBL; M60157; AAA52585.1; JOINED; Genomic_DNA.
DR   EMBL; M60158; AAA52585.1; JOINED; Genomic_DNA.
DR   EMBL; M60159; AAA52585.1; JOINED; Genomic_DNA.
DR   EMBL; M60160; AAA52585.1; JOINED; Genomic_DNA.
DR   EMBL; M60163; AAA52585.1; JOINED; Genomic_DNA.
DR   EMBL; M60162; AAA52586.1; -; Genomic_DNA.
DR   EMBL; M60156; AAA52586.1; JOINED; Genomic_DNA.
DR   EMBL; M60157; AAA52586.1; JOINED; Genomic_DNA.
DR   EMBL; M60158; AAA52586.1; JOINED; Genomic_DNA.
DR   EMBL; M60159; AAA52586.1; JOINED; Genomic_DNA.
DR   EMBL; M60160; AAA52586.1; JOINED; Genomic_DNA.
DR   EMBL; M60161; AAA52586.1; JOINED; Genomic_DNA.
DR   EMBL; M19182; AAA52584.1; -; mRNA.
DR   EMBL; M19184; AAA52584.1; JOINED; Genomic_DNA.
DR   EMBL; AF493894; AAM12608.1; -; mRNA.
DR   EMBL; AF493895; AAM12609.1; -; mRNA.
DR   EMBL; Y18213; CAB46639.1; -; mRNA.
DR   CCDS; CCDS10756.1; -. [P09471-1]
DR   CCDS; CCDS10757.1; -. [P09471-2]
DR   PIR; A40436; RGHUO1.
DR   PIR; B40436; RGHUO2.
DR   RefSeq; NP_066268.1; NM_020988.2. [P09471-1]
DR   RefSeq; NP_620073.2; NM_138736.2. [P09471-2]
DR   UniGene; Hs.644524; -.
DR   ProteinModelPortal; P09471; -.
DR   SMR; P09471; 35-346.
DR   BioGrid; 109037; 40.
DR   IntAct; P09471; 6.
DR   MINT; MINT-1203064; -.
DR   STRING; 9606.ENSP00000262493; -.
DR   BindingDB; P09471; -.
DR   ChEMBL; CHEMBL4742; -.
DR   iPTMnet; P09471; -.
DR   SwissPalm; P09471; -.
DR   BioMuta; GNAO1; -.
DR   DMDM; 232133; -.
DR   EPD; P09471; -.
DR   MaxQB; P09471; -.
DR   PaxDb; P09471; -.
DR   PeptideAtlas; P09471; -.
DR   PRIDE; P09471; -.
DR   DNASU; 2775; -.
DR   Ensembl; ENST00000262493; ENSP00000262493; ENSG00000087258. [P09471-1]
DR   Ensembl; ENST00000262494; ENSP00000262494; ENSG00000087258. [P09471-2]
DR   GeneID; 2775; -.
DR   KEGG; hsa:2775; -.
DR   UCSC; uc002eit.5; human. [P09471-1]
DR   CTD; 2775; -.
DR   GeneCards; GNAO1; -.
DR   HGNC; HGNC:4389; GNAO1.
DR   HPA; CAB008387; -.
DR   HPA; HPA040878; -.
DR   MalaCards; GNAO1; -.
DR   MIM; 139311; gene.
DR   MIM; 615473; phenotype.
DR   neXtProt; NX_P09471; -.
DR   Orphanet; 1934; Early infantile epileptic encephalopathy.
DR   PharmGKB; PA28771; -.
DR   eggNOG; KOG0082; Eukaryota.
DR   eggNOG; ENOG410XNVQ; LUCA.
DR   GeneTree; ENSGT00760000118851; -.
DR   HOGENOM; HOG000038730; -.
DR   HOVERGEN; HBG063184; -.
DR   InParanoid; P09471; -.
DR   KO; K04534; -.
DR   OMA; DSKMVCD; -.
DR   OrthoDB; EOG091G0VUT; -.
DR   PhylomeDB; P09471; -.
DR   TreeFam; TF300673; -.
DR   Reactome; R-HSA-112043; PLC beta mediated events.
DR   Reactome; R-HSA-202040; G-protein activation.
DR   Reactome; R-HSA-4086398; Ca2+ pathway.
DR   Reactome; R-HSA-6814122; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding.
DR   SignaLink; P09471; -.
DR   SIGNOR; P09471; -.
DR   ChiTaRS; GNAO1; human.
DR   GeneWiki; GNAO1; -.
DR   GenomeRNAi; 2775; -.
DR   PRO; PR:P09471; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000087258; -.
DR   CleanEx; HS_GNAO1; -.
DR   ExpressionAtlas; P09471; baseline and differential.
DR   Genevisible; P09471; HS.
DR   GO; GO:0044297; C:cell body; IEA:Ensembl.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0005834; C:heterotrimeric G-protein complex; IBA:GO_Central.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0051430; F:corticotropin-releasing hormone receptor 1 binding; IBA:GO_Central.
DR   GO; GO:0031683; F:G-protein beta/gamma-subunit complex binding; IBA:GO_Central.
DR   GO; GO:0031821; F:G-protein coupled serotonin receptor binding; IBA:GO_Central.
DR   GO; GO:0005525; F:GTP binding; TAS:Reactome.
DR   GO; GO:0003924; F:GTPase activity; TAS:Reactome.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0031852; F:mu-type opioid receptor binding; IBA:GO_Central.
DR   GO; GO:0004871; F:signal transducer activity; IBA:GO_Central.
DR   GO; GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0007212; P:dopamine receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0030900; P:forebrain development; IEA:Ensembl.
DR   GO; GO:0007626; P:locomotory behavior; IEA:Ensembl.
DR   GO; GO:0006936; P:muscle contraction; TAS:ProtInc.
DR   GO; GO:0051926; P:negative regulation of calcium ion transport; IEA:Ensembl.
DR   GO; GO:0031175; P:neuron projection development; IEA:Ensembl.
DR   GO; GO:0043547; P:positive regulation of GTPase activity; IEA:Ensembl.
DR   GO; GO:0006457; P:protein folding; TAS:Reactome.
DR   GO; GO:0008016; P:regulation of heart contraction; IEA:Ensembl.
DR   GO; GO:0034097; P:response to cytokine; IEA:Ensembl.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0042542; P:response to hydrogen peroxide; IEA:Ensembl.
DR   GO; GO:0043278; P:response to morphine; IEA:Ensembl.
DR   GO; GO:0007223; P:Wnt signaling pathway, calcium modulating pathway; TAS:Reactome.
DR   Gene3D; 1.10.400.10; -; 1.
DR   Gene3D; 3.40.50.300; -; 2.
DR   InterPro; IPR001408; Gprotein_alpha_I.
DR   InterPro; IPR001019; Gprotein_alpha_su.
DR   InterPro; IPR011025; GproteinA_insert.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR10218; PTHR10218; 1.
DR   Pfam; PF00503; G-alpha; 1.
DR   PRINTS; PR00318; GPROTEINA.
DR   PRINTS; PR00441; GPROTEINAI.
DR   SMART; SM00275; G_alpha; 1.
DR   SUPFAM; SSF47895; SSF47895; 1.
DR   SUPFAM; SSF52540; SSF52540; 2.
PE   1: Evidence at protein level;
KW   ADP-ribosylation; Alternative splicing; Cell membrane;
KW   Complete proteome; Disease mutation; Epilepsy; GTP-binding;
KW   Lipoprotein; Magnesium; Membrane; Metal-binding; Myristate;
KW   Nucleotide-binding; Palmitate; Reference proteome; Transducer.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:25255805}.
FT   CHAIN         2    354       Guanine nucleotide-binding protein G(o)
FT                                subunit alpha.
FT                                /FTId=PRO_0000203702.
FT   NP_BIND      40     47       GTP. {ECO:0000250}.
FT   NP_BIND     176    182       GTP. {ECO:0000250}.
FT   NP_BIND     201    205       GTP. {ECO:0000250}.
FT   NP_BIND     270    273       GTP. {ECO:0000250}.
FT   METAL        47     47       Magnesium. {ECO:0000250}.
FT   METAL       182    182       Magnesium. {ECO:0000250}.
FT   BINDING     326    326       GTP; via amide nitrogen. {ECO:0000250}.
FT   MOD_RES     179    179       ADP-ribosylarginine; by cholera toxin.
FT                                {ECO:0000250}.
FT   MOD_RES     351    351       ADP-ribosylcysteine; by pertussis toxin.
FT                                {ECO:0000250}.
FT   LIPID         2      2       N-myristoyl glycine.
FT                                {ECO:0000269|PubMed:25255805}.
FT   LIPID         3      3       S-palmitoyl cysteine. {ECO:0000250}.
FT   VAR_SEQ     249    354       MLFDSICNNKFFIDTSIILFLNKKDLFGEKIKKSPLTICFP
FT                                EYTGPNTYEDAAAYIQAQFESKNRSPNKEIYCHMTCATDTN
FT                                NIQVVFDAVTDIIIANNLRGCGLY -> KLFDSICNNKWFT
FT                                DTSIILFLNKKDIFEEKIKKSPLTICFPEYTGPSAFTEAVA
FT                                YIQAQYESKNKSAHKEIYTHVTCATDTNNIQFVFDAVTDVI
FT                                IAKNLRGCGLY (in isoform Alpha-2).
FT                                {ECO:0000303|PubMed:10330115,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_031250.
FT   VARIANT      40     40       G -> R (in EIEE17).
FT                                {ECO:0000269|PubMed:26485252}.
FT                                /FTId=VAR_075416.
FT   VARIANT     174    174       D -> G (in EIEE17; somatic mosaic
FT                                mutation; the mutant protein has some
FT                                abnormal cytoplasmic localization;
FT                                dbSNP:rs587777055).
FT                                {ECO:0000269|PubMed:23993195}.
FT                                /FTId=VAR_070864.
FT   VARIANT     191    197       Missing (in EIEE17; the mutant protein
FT                                accumulates in the cytoplasmic
FT                                compartment; increased basal calcium-
FT                                current density compared to wild-type).
FT                                {ECO:0000269|PubMed:23993195}.
FT                                /FTId=VAR_070865.
FT   VARIANT     203    203       G -> R (in EIEE17; the mutant protein
FT                                localizes normally to the cell periphery;
FT                                dbSNP:rs587777057).
FT                                {ECO:0000269|PubMed:23993195}.
FT                                /FTId=VAR_070866.
FT   VARIANT     279    279       I -> N (in EIEE17; the mutant protein has
FT                                some abnormal cytoplasmic localization;
FT                                dbSNP:rs587777054).
FT                                {ECO:0000269|PubMed:23993195}.
FT                                /FTId=VAR_070867.
FT   CONFLICT     16     16       S -> G (in Ref. 2; AAA52584).
FT                                {ECO:0000305}.
FT   CONFLICT    171    171       T -> L (in Ref. 2; AAA52584).
FT                                {ECO:0000305}.
FT   CONFLICT    218    218       D -> E (in Ref. 2; AAA52584).
FT                                {ECO:0000305}.
SQ   SEQUENCE   354 AA;  40051 MW;  4F182926A8106E3E CRC64;
     MGCTLSAEER AALERSKAIE KNLKEDGISA AKDVKLLLLG AGESGKSTIV KQMKIIHEDG
     FSGEDVKQYK PVVYSNTIQS LAAIVRAMDT LGIEYGDKER KADAKMVCDV VSRMEDTEPF
     SAELLSAMMR LWGDSGIQEC FNRSREYQLN DSAKYYLDSL DRIGAADYQP TEQDILRTRV
     KTTGIVETHF TFKNLHFRLF DVGGQRSERK KWIHCFEDVT AIIFCVALSG YDQVLHEDET
     TNRMHESLML FDSICNNKFF IDTSIILFLN KKDLFGEKIK KSPLTICFPE YTGPNTYEDA
     AAYIQAQFES KNRSPNKEIY CHMTCATDTN NIQVVFDAVT DIIIANNLRG CGLY
//
